4,116
Participants
Start Date
November 30, 2002
Primary Completion Date
April 30, 2004
Study Completion Date
April 30, 2004
Combined diphtheria, tetanus, acellular pertussis vaccine
GSK Investigational Site, New Bedford
GSK Investigational Site, Stony Brook
GSK Investigational Site, Rochester
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Sellersville
GSK Investigational Site, Norfolk
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Durham
GSK Investigational Site, Lumberton
GSK Investigational Site, Jacksonville
GSK Investigational Site, Kingsport
GSK Investigational Site, Bardstown
GSK Investigational Site, Cleveland
GSK Investigational Site, University Heights
GSK Investigational Site, Chicago
GSK Investigational Site, Omaha
GSK Investigational Site, Little Rock
GSK Investigational Site, Jonesboro
GSK Investigational Site, Temple
GSK Investigational Site, Houston
GSK Investigational Site, Bryan
GSK Investigational Site, Georgetown
GSK Investigational Site, Centennial
GSK Investigational Site, Boulder
GSK Investigational Site, Golden
GSK Investigational Site, West Jordan
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Mesa
GSK Investigational Site, Tempe
GSK Investigational Site, Rolling Hills Est
GSK Investigational Site, Redondo Beach
GSK Investigational Site, Torrance
GSK Investigational Site, Escondido
GSK Investigational Site, Fullerton
GSK Investigational Site, Yorba Linda
GSK Investigational Site, Middletown
GSK Investigational Site, Norwich
GSK Investigational Site, Boston
GSK Investigational Site, Boston
GSK Investigational Site, Milford
GSK Investigational Site, Woburn
GSK Investigational Site, Whitehouse Station
GSK Investigational Site, Akron
GSK Investigational Site, Pittsburgh
Lead Sponsor
GlaxoSmithKline
INDUSTRY